Table 4.
Control group (n=112) | Experimental group (n=96) | χ2 | P | |
---|---|---|---|---|
Artificial rupture of membranes (n, %) | 12 (10.71) | 4 (4.17) | 4.627 | 0.032 |
Intravenous use of oxytocin (n, %) | 21 (18.75) | 8 (8.33) | 7.726 | 0.005 |
Control group (n=112) | Experimental group (n=96) | χ2 | P | |
---|---|---|---|---|
Artificial rupture of membranes (n, %) | 12 (10.71) | 4 (4.17) | 4.627 | 0.032 |
Intravenous use of oxytocin (n, %) | 21 (18.75) | 8 (8.33) | 7.726 | 0.005 |